Oral dosage forms comprising 3-pyridyl-1-hydroxy-ethylidene-1,1-bisphosphonic acid (risedronate) and having an enteric coating to delay release until the lower intestinal tract
Номер патента: NZ245214A
Опубликовано: 28-05-1999
Автор(ы): D W Axelrod, R J Dansereau, R Y Mosher, W K Sietsema
Принадлежит: Procter & Gamble Pharma
Опубликовано: 28-05-1999
Автор(ы): D W Axelrod, R J Dansereau, R Y Mosher, W K Sietsema
Принадлежит: Procter & Gamble Pharma
Risedronate delayed-release compositions
Номер патента: CA2122479C. Автор: Richard John Dansereau,Russell Youker Mosher,Douglas Wayne Axelrod,William Kendall Sietsema. Владелец: Procter and Gamble Pharmaceuticals Inc. Дата публикации: 1998-08-25.